Moolenaar F - Search Results

1

Rectal drug administration: clinical pharmacokinetic considerations.

de Boer AG, Moolenaar F, de Leede LG, Breimer DD. de Boer AG, et al. Among authors: moolenaar f. Clin Pharmacokinet. 1982 Jul-Aug;7(4):285-311. doi: 10.2165/00003088-198207040-00002. Clin Pharmacokinet. 1982. PMID: 6126289 Review.

2

Preliminary study on the absorption profile after rectal and oral administration of methadone in human volunteers.

Moolenaar F, Fiets G, Visser J, Meijer DK. Moolenaar F, et al. Pharm Weekbl Sci. 1984 Dec 14;6(6):237-40. doi: 10.1007/BF01954551. Pharm Weekbl Sci. 1984. PMID: 6549062

3

Rectal absorption of metronidazole from polyethylene glycol suppositories.

Vromans H, Moolenaar F, Visser J, Meijer DK. Vromans H, et al. Among authors: moolenaar f. Pharm Weekbl Sci. 1984 Feb 24;6(1):18-20. doi: 10.1007/BF01960193. Pharm Weekbl Sci. 1984. PMID: 6709483

4

Rectal versus oral absorption of codeine phosphate in man.

Moolenaar F, Grasmeijer G, Visser J, Meijer DK. Moolenaar F, et al. Biopharm Drug Dispos. 1983 Apr-Jun;4(2):195-9. doi: 10.1002/bdd.2510040212. Biopharm Drug Dispos. 1983. PMID: 6683976 Clinical Trial.

5

Drastic improvement in the rectal absorption profile of morphine in man.

Moolenaar F, Yska JP, Visser J, Meijer DK. Moolenaar F, et al. Eur J Clin Pharmacol. 1985;29(1):119-21. doi: 10.1007/BF00547380. Eur J Clin Pharmacol. 1985. PMID: 4054201

6

Absorption rate and bioavailability of valproic acid and its sodium from rectal dosage forms.

Moolenaar F, Greving WJ, Huizinga T. Moolenaar F, et al. Eur J Clin Pharmacol. 1980 Apr;17(4):309-15. doi: 10.1007/BF00625806. Eur J Clin Pharmacol. 1980. PMID: 6772450 Clinical Trial. No abstract available.

7

A study on the buffering activity of the human rectum. In vivo demonstration of HCO3- and H+ secretion after rectal application of fluids with an unphysiological pH.

Böttger WM, Schoonen BJ, Moolenaar F, Visser J, Meijer DK. Böttger WM, et al. Among authors: moolenaar f. Pharm Weekbl Sci. 1989 Feb 24;11(1):9-12. doi: 10.1007/BF01972908. Pharm Weekbl Sci. 1989. PMID: 2540479

8

Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme.

Franssen EJ, van Amsterdam RG, Visser J, Moolenaar F, de Zeeuw D, Meijer DK. Franssen EJ, et al. Among authors: moolenaar f. Pharm Res. 1991 Oct;8(10):1223-30. doi: 10.1023/a:1015835325321. Pharm Res. 1991. PMID: 1796038

9

Clearance of indomethacin occurs predominantly by renal glucuronidation.

Moolenaar F, Crancrinus S, Visser J, De Zeeuw D, Meijer DK. Moolenaar F, et al. Pharm Weekbl Sci. 1992 Aug 21;14(4):191-5. doi: 10.1007/BF01962537. Pharm Weekbl Sci. 1992. PMID: 1437498

10

Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.

Franssen EJ, Koiter J, Kuipers CA, Bruins AP, Moolenaar F, de Zeeuw D, Kruizinga WH, Kellogg RM, Meijer DK. Franssen EJ, et al. Among authors: moolenaar f. J Med Chem. 1992 Apr 3;35(7):1246-59. doi: 10.1021/jm00085a012. J Med Chem. 1992. PMID: 1560438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results